Viral vectors and Viruses

Vaccines have a long and successful history of inducing immunity to diseases, and they are expected to play an equally beneficial role in the future. Many of the biotechnology drugs in the development pipeline fall into these product categories. Methods of developing vaccines and gene therapy products are highly varied and present a very wide range of separation problems.

Purification targets vary from viruses to plasmids (pDNA), virus like particles, native and recombinant proteins and protein conjugate.

GE Healthcare is actively developing products and methodologies for these targets that involve a range of techniques including affinity, hydrophobic interaction, ion exchange and gel filtration chromatography, plus expanded bed adsorption. Read about these applications developed by us or our customers under related documents.